These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25980509)

  • 21. Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study.
    Schiele MA; Zwanzger P; Schwarte K; Arolt V; Baune BT; Domschke K
    Int J Neuropsychopharmacol; 2021 Mar; 24(3):191-199. PubMed ID: 33125470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.
    Fabbri C; Hosak L; Mössner R; Giegling I; Mandelli L; Bellivier F; Claes S; Collier DA; Corrales A; Delisi LE; Gallo C; Gill M; Kennedy JL; Leboyer M; Lisoway A; Maier W; Marquez M; Massat I; Mors O; Muglia P; Nöthen MM; O'Donovan MC; Ospina-Duque J; Propping P; Shi Y; St Clair D; Thibaut F; Cichon S; Mendlewicz J; Rujescu D; Serretti A
    World J Biol Psychiatry; 2017 Feb; 18(1):5-28. PubMed ID: 27603714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.
    Kato M; Serretti A
    Mol Psychiatry; 2010 May; 15(5):473-500. PubMed ID: 18982004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
    Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Tencomnao T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):432; author reply 433. PubMed ID: 20036298
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions.
    Marshe VS; Islam F; Maciukiewicz M; Bousman C; Eyre HA; Lavretsky H; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
    Am J Geriatr Psychiatry; 2020 Jun; 28(6):609-629. PubMed ID: 32122803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
    Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
    Peterson K; Dieperink E; Anderson J; Boundy E; Ferguson L; Helfand M
    Psychopharmacology (Berl); 2017 Jun; 234(11):1649-1661. PubMed ID: 28456840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic tests for controlling treatment with antidepressants].
    Bschor T; Baethge C; Hiemke C; Müller-Oerlinghausen B
    Nervenarzt; 2017 May; 88(5):495-499. PubMed ID: 28303314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
    Miller DB; O'Callaghan JP
    Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.
    Shalimova A; Babasieva V; Chubarev VN; Tarasov VV; Schiöth HB; Mwinyi J
    Pharmacogenomics; 2021 Jun; 22(8):485-503. PubMed ID: 34018822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.
    Bousman CA; Dunlop BW
    Pharmacogenomics J; 2018 Sep; 18(5):613-622. PubMed ID: 29795409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M
    Psychiatr Danub; 2008 Sep; 20(3):399-401. PubMed ID: 18827770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression.
    Okada S; Morinobu S; Fuchikami M; Segawa M; Yokomaku K; Kataoka T; Okamoto Y; Yamawaki S; Inoue T; Kusumi I; Koyama T; Tsuchiyama K; Terao T; Kokubo Y; Mimura M
    J Psychiatr Res; 2014 Jun; 53():47-53. PubMed ID: 24657235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
    Fabbri C; Di Girolamo G; Serretti A
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics and antidepressant drugs.
    Binder EB; Holsboer F
    Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.